Skip to main content
Have a personal or library account? Click to login
Diagnostic performance of the systemic inflammation response index and aggregate index of systemic inflammation in polycystic ovary syndrome: A ROC curve analysis Cover

Diagnostic performance of the systemic inflammation response index and aggregate index of systemic inflammation in polycystic ovary syndrome: A ROC curve analysis

Open Access
|Apr 2026

References

  1. Begum G, Almashaikhi N, Albalushi M, Alsalehi H, Alazawi R, Goud B, et al. Prevalence of polycystic ovary syndrome (PCOS) and its associated risk factors among medical students in two countries. Int J Environ Res Public Health. 2024;21(9):1165. DOI: 10.3390/ijerph21091165
  2. World Health Organization. Polycystic ovary syndrome [Internet]. Geneva: WHO; 2023 Jun 8 [cited 2024 Jun 1]. Available from: www.who.int
  3. Dason E, Koshkina O, Chan C, Sobel M. Diagnosis and management of polycystic ovarian syndrome. CMAJ. 2024;196(3):E85 E94. DOI: 10.1503/cmaj.231251
  4. Merkin S, Phy J, Sites C, Yang D. Environmental determinants of polycystic ovary syndrome. Fertil Steril. 2016;106(1):16 24. DOI: 10.1016/j.fertnstert.2016.05.011
  5. Teede H, Misso M, Costello M, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602 1618. DOI: 10.1093/humrep/dey256
  6. Tosi F, Bonora E, Moghetti P. Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes. Hum Reprod. 2017;32(12):2515 2521. DOI: 10.1093/humrep/dex308
  7. Deng H, Chen Y, Xing J, Zhang N, Xi L. Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome. Front Immunol. 2024;15:1504358. DOI: 10.3389/fimmu.2024.1470283
  8. Abdulkhaleq LA, Assi MA, Abdullah R, Zamri-Saad M, Taufiq-Yap YH, Hezmee MNM. The crucial roles of inflammatory mediators in inflammation: a review. Vet World. 2018;11(5):627 635. DOI: 10.14202/vetworld.2018.627-635
  9. Kindan A, Kindan G, Soysal Ç, Turan V. PCOS phenotypes and hematological immune-inflammatory indices: a comparative evaluation. J Reprod Immunol. 2025;173:104823. DOI: 10.1016/j. jri.2025.104823
  10. Ballerini P, Contursi A, Bruno A, Mucci M, Tacconelli S, Patrignani P. Inflammation and cancer: from the development of personalized indicators to novel therapeutic strategies. Front Pharmacol. 2022;13:838079. DOI: 10.3389/fphar.2022.838079
  11. Gürbüz T, Madenli A, Çetiner S. The relationship between polycystic ovary syndrome phenotypes and systemic immune-inflammation (SII) and response (SIRI) indices. J Controv Obstetr Gynecol Ped. 2025;3(1):1 8. DOI: 10.51271/JCOGP-0039
  12. Hosseninia S, Ghobadi H, Garjani K, Hosseini S, Aslani M. Aggregate index of systemic inflammation (AISI) in admission as a reliable predictor of mortality in COPD patients with COVID-19. BMC Pulm Med. 2023;23:107. DOI: 10.1186/s12890-023-02397-5
  13. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41 47. DOI: 10.1093/humrep/deh098
  14. Gnanadass S, Prabhu Y, Gopalakrishnan A. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Arch Gynecol Obstet. 2021;303(3):631 643. DOI: 10.1007/s00404-020-05951-2
  15. Hatziagelaki E, Pergialiotis V, Kannenberg J, Trakakis E, Tsiavou A , Markgraf D, et al. Association between biomarkers of low-grade inflammation and sex hormones in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2020;128(11):723 730. DOI: 10.1055/a-0992-9114
  16. Rudnicka E, Suchta K, Grymowicz M, Calik-Ksepka A, Smolarczyk K, Duszewska A, et al. Chronic low grade inflammation in pathogenesis of polycystic ovary syndrome. Int J Mol Sci. 2021;22(7):3789. DOI: 10.3390/ijms22073789
  17. Qu J, Li B, Qiu M, Wang J, Chen Z, Li K, et al. Discovery of immune-related diagnostic biomarkers and construction of diagnostic model in various polycystic ovary syndrome. Arch Gynecol Obstet. 2022;306(5):1607 1615. DOI: 10.1007/s00404-022-06686-y
  18. Luan YY, Zhang L, Peng YQ, Li YY, Lui RX, Yin CH. Immune regulation in polycystic ovary syndrome. Clin Chim Acta. 2022;531:265 272. DOI: 10.1016/j.cca.2022.04.234
  19. Zorlu U, Turgay B, Yılmazer-Zorlu S, Halilzade M, Halilzade I, Yalçın H. Investigation of the relationship between clinical features and the sonographic appearance of the ovaries with the delta neutrophil index in polycystic ovary syndrome. JBRA Assist Reprod. 2025;29(3):333 337. DOI: 10.5935/1518-0557.20250014
  20. Ozkan H, Ozkan M, Dayanan R, Bulan D, Filiz A , Engin-Ustun Y. Inflammatory status and clinical phenotypes of PCOS: the role of NLR, SII, SIRI, and AISI. BMC Womens Health. 2025;25(1):463. DOI: 10.1186/s12905-025-04033-2
DOI: https://doi.org/10.2478/rrlm-2026-0016 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 137 - 142
Submitted on: Feb 5, 2026
Accepted on: Mar 2, 2026
Published on: Apr 24, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Natalia Nikolaeva Dikova, Petya Andreeva, Ivanka Dimova, Milena Velizarova, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.